Investing.com - Financial Markets Worldwide
🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Avicanna Inc (AVCN)

Toronto
Currency in CAD
0.330
+0.020(+6.45%)
Real-time Data
AVCN Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Unlock Value
Day's Range
0.3100.330
52 wk Range
0.2000.600
Key Statistics
Edit
Bid/Ask
0.33 / 0.34
Prev. Close
0.31
Open
0.31
Day's Range
0.31-0.33
52 wk Range
0.2-0.6
Volume
49.78K
Average Volume (3m)
164.15K
1-Year Change
-36.73%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVCN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
pro lock
Unlock All 9
Stock price movements are quite volatile
Unlock InvestingPro

Avicanna Inc News & Analysis

Show more

Avicanna Company Profile

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets worldwide. It commercializes approximately thirty proprietary evidence-based finished products. The company provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific pharmaceutical products to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, such as Trunerox, an adjuvant treatment for seizures associated with Lennox-Gastaut Syndrome and Dravet Syndrome. It also offers active pharmaceutical ingredients comprising various cannabidiol, tetrahydrocannabinol, and cannabigerol for use in the development and production of food, cosmetics, medical, and pharmaceutical products under the Aureus Santa Marta brand. In addition, the company operates MyMedi.ca, a medical cannabis care platform that offers a diverse portfolio of products and bilingual pharmacist-led patient support programs, specialty services to veterans, and educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens, as well as collaborates with public and private payers for adjudication and reimbursement. The company has a research and collaboration agreement with a multinational European based pharmaceutical company to assess its proprietary SEDDS technology in combination with Collaborator’s various drug delivery and pharmaceutical formats. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
87
Market
Canada

Compare AVCN to Peers and Sector

Metrics to compare
AVCN
Peers
Sector
Relationship
P/E Ratio
−5.0x−2.0x−0.7x
PEG Ratio
−0.10−0.010.00
Price/Book
19.9x0.3x2.6x
Price / LTM Sales
1.4x1.4x3.2x
Upside (Analyst Target)
-41.5%47.0%
Fair Value Upside
Unlock14.9%7.5%Unlock

FAQ

What Is the Avicanna (AVCN) Stock Price Today?

The Avicanna stock price today is 0.33.

What Stock Exchange Does Avicanna Trade On?

Avicanna is listed and trades on the Toronto stock exchange.

What Is the Stock Symbol for Avicanna?

The stock symbol for Avicanna is "AVCN."

What Is the Avicanna Market Cap?

As of today, Avicanna market cap is 34.17M.

What is Avicanna Earnings Per Share?

The Avicanna EPS is -0.071.

From a Technical Analysis Perspective, Is AVCN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.